摘要
How Ebola virus(EBOV)enters a host cell remains intriguingly mysterious to the public.Recently,a study led by George F Gao and his colleagues has unveiled how the primed glycoprotein on the envelope of EBOV binds to its endosomal receptor Niemann-Pick C1(NPC1)molecule during the process of virus membrane fusion with the host cells,an essential step for viral entry(Wang et al.,2016).This fine resolution of the viral glycoprotein with NPC1 at the atomic level sheds light on the development of therapeutic inhibitors against EBOV infection.
How Ebola virus（EBOV）enters a host cell remains intriguingly mysterious to the public.Recently,a study led by George F Gao and his colleagues has unveiled how the primed glycoprotein on the envelope of EBOV binds to its endosomal receptor Niemann-Pick C1（NPC1）molecule during the process of virus membrane fusion with the host cells,an essential step for viral entry（Wang et al.,2016）.This fine resolution of the viral glycoprotein with NPC1 at the atomic level sheds light on the development of therapeutic inhibitors against EBOV infection.
